Physician profile
Scott David Davidson
NPI 1568495398
$5,694.65
in general payments reported to CMS, 2019-2025
51 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $302 · 2021: $256 · 2022: $766 · 2023: $727 · 2024: $932 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,583.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $699.87 | 2019-2025 | Provenge |
| Antares Pharma, INC. | $505.53 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Ferring Pharmaceuticals INC. | $395.05 | 2019-2025 | Adstiladrin |
| Astellas Pharma US INC | $372.76 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $367.34 | 2019-2025 | |
| Procept Biorobotics Corporation | $333.09 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $320.44 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Lithovue |
| Merck Sharp & Dohme LLC | $220.35 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $214.93 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $188.47 | 2020-2025 | Erleada |
| Sumitomo Pharma America, INC. | $149.70 | 2023-2024 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $146.24 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $139.46 | 2019-2023 | Yonsa |
| Storz Medical America, INC. | $137.53 | 2025 | |
| Endo Pharmaceuticals INC. | $115.22 | 2019-2024 | Xiaflex, Aveed |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.